Cargando…
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases
OBJECTIVE: To identify and characterize autoantibodies (Abs) as novel biomarkers for an autoimmune context in patients with central and peripheral neurologic diseases. METHODS: Two distinct approaches (immunoprecipitation/mass spectrometry–based proteomics and protein microarrays) and patients'...
Autores principales: | Do, Le-Duy, Moritz, Christian P., Muñiz-Castrillo, Sergio, Pinto, Anne-Laurie, Tholance, Yannick, Brugiere, Sabine, Couté, Yohann, Stoevesandt, Oda, Taussig, Michael J., Rogemond, Véronique, Vogrig, Alberto, Joubert, Bastien, Ferraud, Karine, Camdessanché, Jean-Philippe, Antoine, Jean-Christophe, Honnorat, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362341/ https://www.ncbi.nlm.nih.gov/pubmed/34321331 http://dx.doi.org/10.1212/NXI.0000000000001032 |
Ejemplares similares
-
CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach
por: Moritz, Christian P., et al.
Publicado: (2021) -
Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies
por: Moritz, Christian P., et al.
Publicado: (2022) -
Associations between HLA and autoimmune neurological diseases with autoantibodies
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2020) -
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2020) -
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes
por: Déchelotte, Benoît, et al.
Publicado: (2020)